Literature DB >> 12557284

Assessing the onset of structural change in familial Alzheimer's disease.

Jonathan M Schott1, Nick C Fox, Chris Frost, Rachael I Scahill, John C Janssen, Dennis Chan, Rhian Jenkins, Martin N Rossor.   

Abstract

Regional and global cerebral atrophy are inevitable features of Alzheimer's disease (AD). We assessed volumes and atrophy rates of brain structures in patients with familial AD during the period that they developed symptoms. Five patients with presymptomatic AD and 20 controls had two or more annual volumetric MRI brain scans. Volumes of brain, ventricles, temporal lobes, hippocampi, and entorhinal cortices (ECs) were measured. Rates of volume change were calculated from serial scans. There were no significant differences in baseline measures of whole brain, temporal lobe, or ventricular volume between patients and controls; averaged volumes of medial temporal lobe structures (both hippocampi and ECs) were 16.6% (95% confidence interval [CI], 3.3-28.0%) lower in patients. Atrophy rates for brain, temporal lobe, hippocampus, and EC were significantly increased in patients compared with controls (p < 0.05). Averaged atrophy rates from both hippocampi and ECs were 5.1% (95% CI, 3.0-7.1%) greater in patients than controls. Linear extrapolation backward suggested medial temporal lobe atrophy commenced 3.5 years (95% CI, 0.7-7.5 years) before onset, when all patients were asymptomatic. We conclude that increased medial temporal lobe atrophy rates are an early and distinguishing feature of AD and that pathological atrophy probably is occurring several years before the onset of symptoms.

Entities:  

Mesh:

Year:  2003        PMID: 12557284     DOI: 10.1002/ana.10424

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  62 in total

Review 1.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

2.  Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.

Authors:  Liana G Apostolova; Kristy S Hwang; Luis D Medina; Amity E Green; Meredith N Braskie; Rebecca A Dutton; Jeffrey Lai; Daniel H Geschwind; Jeffrey L Cummings; Paul M Thompson; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-09-23       Impact factor: 2.959

3.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Authors:  C R Jack; M M Shiung; S D Weigand; P C O'Brien; J L Gunter; B F Boeve; D S Knopman; G E Smith; R J Ivnik; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

Review 5.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

6.  Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Authors:  B C Dickerson; T R Stoub; R C Shah; R A Sperling; R J Killiany; M S Albert; B T Hyman; D Blacker; L Detoledo-Morrell
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

Review 7.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

8.  Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment.

Authors:  Sarah B Martin; Charles D Smith; Heather R Collins; Fred A Schmitt; Brian T Gold
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

Review 9.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

10.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.

Authors:  T den Heijer; S E Vermeer; E J van Dijk; N D Prins; P J Koudstaal; A Hofman; M M B Breteler
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.